Similarly, aberrant FGF19 and its receptor FGFR4 have been identified as oncogenic drivers for a subset of HCC, and their presence is associated with a poor prognosis for HCC patients (70, 71). The gene discussed is FGFR4; the disease is hepatocellular carcinoma.